Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds

PURPOSE: (18)F-Florbetapir has been reported to show cardiac uptake in patients with systemic light-chain amyloidosis (AL). This study systematically assessed uptake of (18)F-florbetapir in patients with proven systemic amyloidosis at sites outside the heart. METHODS: Seventeen patients with proven...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953997/
https://www.ncbi.nlm.nih.gov/pubmed/29651545
http://dx.doi.org/10.1007/s00259-018-3995-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953997/
https://www.ncbi.nlm.nih.gov/pubmed/29651545
http://dx.doi.org/10.1007/s00259-018-3995-2

Ejemplares similares